Ionis' Tryngolza Achieves Milestone as the First Therapy Approved by FDA for Familial Chylomicronemia Syndrome

Ionis’ Tryngolza Achieves Milestone as the First Therapy Approved by FDA for Familial Chylomicronemia Syndrome

Ionis' Tryngolza Achieves Milestone as the First Therapy Approved by FDA for Familial Chylomicronemia Syndrome